Scancell Holdings Plc (LON:SCLP) passed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $5.91 and traded as high as $6.10. Scancell shares last traded at $6.25, with a volume of 55,328 shares.

The stock has a market cap of $29.09 million and a PE ratio of -4.17. The stock has a fifty day simple moving average of GBX 5.93 and a two-hundred day simple moving average of GBX 6.65.

In related news, insider Martin Diggle purchased 2,925,000 shares of the firm’s stock in a transaction on Monday, December 16th. The stock was purchased at an average price of GBX 5 ($0.07) per share, for a total transaction of £146,250 ($192,383.58).

About Scancell (LON:SCLP)

Scancell Holdings plc engages in the discovery and development of novel monoclonal antibodies and vaccines for the treatment of cancer in the United Kingdom. The company's products include SCIB1, a plasmid DNA vaccine, which is in Phase I/II clinical trials for the treatment of melanoma; SCIB2 to treat lung cancer antigen; and Modi-1, which is in the pre-clinical development to treat triple negative breast cancer, ovarian cancer, and sarcoma.

Featured Article: What is an overbought condition?

Receive News & Ratings for Scancell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scancell and related companies with MarketBeat.com's FREE daily email newsletter.